HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wei Cao Selected Research

miniplasmin

1/2013Purification and characterization of mutant miniPlasmin for thrombolytic therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wei Cao Research Topics

Disease

135Neoplasms (Cancer)
10/2022 - 08/2002
45Inflammation (Inflammations)
01/2022 - 11/2005
22Fibrosis (Cirrhosis)
01/2022 - 12/2011
22Squamous Cell Carcinoma of Head and Neck
06/2021 - 11/2010
17Infections
05/2022 - 09/2005
16COVID-19
12/2022 - 01/2020
14Neoplasm Metastasis (Metastasis)
12/2022 - 04/2012
13Lung Neoplasms (Lung Cancer)
01/2022 - 02/2006
12Body Weight (Weight, Body)
04/2022 - 01/2010
12Carcinogenesis
03/2022 - 11/2011
12Breast Neoplasms (Breast Cancer)
01/2022 - 06/2012
11Virus Diseases (Viral Diseases)
01/2022 - 02/2007
11Rheumatoid Arthritis
09/2021 - 12/2009
11Carcinoma (Carcinomatosis)
06/2020 - 08/2002
10Esophageal Squamous Cell Carcinoma
06/2022 - 01/2013
9Alzheimer Disease (Alzheimer's Disease)
01/2022 - 12/2012
9Wounds and Injuries (Trauma)
02/2021 - 01/2017
8Mitochondrial Diseases (Mitochondrial Disease)
01/2022 - 01/2016
8Pain (Aches)
01/2022 - 06/2008
8Obesity
01/2022 - 02/2014
8Hypoxia (Hypoxemia)
10/2021 - 05/2008
8Hepatocellular Carcinoma (Hepatoma)
10/2021 - 08/2007
8Pancreatic Neoplasms (Pancreatic Cancer)
09/2021 - 02/2011
8Autoimmune Diseases (Autoimmune Disease)
11/2016 - 10/2007
7Reperfusion Injury
01/2022 - 06/2012
7Necrosis
09/2021 - 01/2013
7Liver Cirrhosis (Hepatic Cirrhosis)
03/2021 - 02/2014
7Stomach Neoplasms (Stomach Cancer)
01/2019 - 10/2005
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2022 - 01/2012
6Insulin Resistance
03/2022 - 11/2012
6Chronic Obstructive Pulmonary Disease (COPD)
01/2022 - 01/2019
6HIV Infections (HIV Infection)
07/2021 - 04/2015
6Acute Kidney Injury (Acute Renal Failure)
09/2020 - 09/2017
6Proteinuria
01/2020 - 06/2006
6Experimental Arthritis
08/2019 - 01/2016
6Atherosclerosis
01/2018 - 01/2005
5Hemorrhage
03/2022 - 09/2014
5Sepsis (Septicemia)
01/2022 - 08/2009
5Melanoma (Melanoma, Malignant)
01/2022 - 01/2014
5Chronic Renal Insufficiency
11/2021 - 10/2012
5Myocardial Infarction
01/2021 - 01/2012
5Atrial Fibrillation
01/2021 - 10/2014
5Psoriasis (Pustulosis Palmaris et Plantaris)
01/2021 - 10/2007
5Chronic Urticaria
08/2020 - 06/2019
5Liver Neoplasms (Liver Cancer)
06/2020 - 08/2002
5Hypertrophy
01/2020 - 07/2010
5Cardiovascular Diseases (Cardiovascular Disease)
01/2020 - 08/2009
5Glioma (Gliomas)
12/2019 - 06/2015

Drug/Important Bio-Agent (IBA)

46Proteins (Proteins, Gene)FDA Link
03/2022 - 08/2004
30Biomarkers (Surrogate Marker)IBA
12/2022 - 11/2010
24Pharmaceutical PreparationsIBA
04/2022 - 12/2008
23Long Noncoding RNAIBA
06/2022 - 01/2013
18CytokinesIBA
10/2022 - 02/2007
17Messenger RNA (mRNA)IBA
08/2020 - 06/2005
16Biological ProductsIBA
07/2021 - 03/2013
13Glucose (Dextrose)FDA LinkGeneric
03/2022 - 05/2008
12Therapeutic UsesIBA
01/2022 - 04/2008
11DNA (Deoxyribonucleic Acid)IBA
01/2022 - 10/2007
11EnzymesIBA
01/2022 - 01/2007
10CollagenIBA
01/2022 - 01/2002
10AntioxidantsIBA
01/2021 - 01/2012
9Polysaccharides (Glycans)IBA
03/2022 - 02/2008
9Peptides (Polypeptides)IBA
01/2022 - 01/2007
9RNA (Ribonucleic Acid)IBA
01/2022 - 06/2007
9Indicators and Reagents (Reagents)IBA
07/2020 - 06/2012
8AntigensIBA
05/2022 - 06/2005
8Reactive Oxygen Species (Oxygen Radicals)IBA
04/2022 - 08/2014
8Phosphotransferases (Kinase)IBA
01/2022 - 12/2011
8InterferonsIBA
01/2022 - 10/2007
8MicroRNAs (MicroRNA)IBA
01/2021 - 07/2015
8Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2017 - 05/2005
7Amyloid (Amyloid Fibrils)IBA
10/2022 - 01/2013
7Interferon Type IIBA
10/2022 - 02/2007
7Doxorubicin (Adriamycin)FDA LinkGeneric
10/2022 - 08/2002
7AntibodiesIBA
10/2022 - 09/2012
7Cisplatin (Platino)FDA LinkGeneric
01/2022 - 01/2017
7Small Interfering RNA (siRNA)IBA
01/2021 - 06/2012
6Immunoglobulin G (IgG)IBA
04/2022 - 10/2012
6Oxygen (Dioxygen)IBA
01/2022 - 10/2016
6Eosine Yellowish-(YS) (Eosin)IBA
04/2021 - 03/2012
6Hematoxylin (Haematoxylon)IBA
04/2021 - 03/2012
6VaccinesIBA
01/2021 - 09/2005
6Caspase 3 (Caspase-3)IBA
11/2020 - 11/2011
6Enhancer of Zeste Homolog 2 ProteinIBA
06/2020 - 11/2011
6LigandsIBA
01/2020 - 06/2007
5Interleukin-6 (Interleukin 6)IBA
01/2022 - 01/2014
5LipidsIBA
01/2022 - 08/2010
5Triglycerides (Triacylglycerol)IBA
10/2021 - 08/2010
5Nucleic AcidsIBA
06/2021 - 08/2008
5Cadherins (E-Cadherin)IBA
06/2021 - 06/2014
5Intravenous Immunoglobulins (IVIG)FDA Link
01/2021 - 01/2020
5Antiviral Agents (Antivirals)IBA
01/2021 - 08/2008
5Malondialdehyde (Propanedial)IBA
09/2020 - 06/2015
5SpermineIBA
01/2020 - 03/2017
5ResveratrolIBA
12/2019 - 01/2016

Therapy/Procedure

72Therapeutics
10/2022 - 04/2007
11Drug Therapy (Chemotherapy)
10/2022 - 05/2005
7Chinese Traditional Medicine (Traditional Chinese Medicine)
10/2019 - 01/2010
6Art Therapy
07/2021 - 01/2016
5Immunotherapy
10/2022 - 06/2015